Matching chelators to radiometals for radiopharmaceuticals (Q38156660)

29 August 2017

title

Matching chelators to radiometals for radiopharmaceuticals (English)

1 reference

29 August 2017

Eric W Price

1

1 reference

29 August 2017

Chris Orvig

series ordinal

2

1 reference

29 August 2017

publication date

30 October 2013

1 reference

29 August 2017

published in

Chemical Society Reviews

1 reference

29 August 2017

volume

43

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

260-290

1 reference

HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts

29 August 2017

cites work

1 reference

Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

Theranostics: Combining Imaging and Therapy

21 January 2018

1 reference

Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?

21 January 2018

1 reference

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

21 January 2018

1 reference

Stability of (47)Sc-complexes with acyclic polyamino-polycarboxylate ligands.

21 January 2018

1 reference

Tumour targeting with radiometals for diagnosis and therapy

21 January 2018

1 reference

A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

21 January 2018

1 reference

The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals

21 January 2018

1 reference

A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.

21 January 2018

1 reference

Synthesis and in vivo imaging of a 18F-labeled PARP1 inhibitor using a chemically orthogonal scavenger-assisted high-performance method.

21 January 2018

1 reference

Bioorthogonal reaction pairs enable simultaneous, selective, multi-target imaging

21 January 2018

1 reference

Synthesis and evaluation of a series of 1,2,4,5-tetrazines for bioorthogonal conjugation

21 January 2018

1 reference

Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era.

21 January 2018

1 reference

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

21 January 2018

1 reference

(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives

21 January 2018

1 reference

The next generation of positron emission tomography radiopharmaceuticals in oncology.

21 January 2018

1 reference

Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides

21 January 2018

1 reference

Copper chelation chemistry and its role in copper radiopharmaceuticals.

21 January 2018

1 reference

Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

21 January 2018

1 reference

Immuno-PET: a navigator in monoclonal antibody development and applications.

21 January 2018

1 reference

Radiometals for combined imaging and therapy

21 January 2018

1 reference

Iodine-124: a promising positron emitter for organic PET chemistry

21 January 2018

1 reference

Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications

21 January 2018

1 reference

68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals

21 January 2018

1 reference

The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications

21 January 2018

1 reference

Radiometallated peptides for molecular imaging and targeted therapy.

21 January 2018

1 reference

Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry

21 January 2018

1 reference

Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals

21 January 2018

1 reference

Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies.

21 January 2018

1 reference

Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.

21 January 2018

1 reference

In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver.

21 January 2018

1 reference

Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase

21 January 2018

1 reference

Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium.

21 January 2018

1 reference

H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy

21 January 2018

1 reference

H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu

21 January 2018

1 reference

Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals.

21 January 2018

1 reference

Development of an in vitro model for assessing the in vivo stability of lanthanide chelates

21 January 2018

1 reference

Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability

21 January 2018

1 reference

Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction

21 January 2018

1 reference

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

21 January 2018

1 reference

Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for (90)Y- and (111)In-labeled DOTA-biomolecule conjugates

21 January 2018

1 reference

Synthesis of target-specific radiolabeled peptides for diagnostic imaging

21 January 2018

1 reference

Imaging of protein synthesis: in vitro and in vivo evaluation of (44)Sc-DOTA-puromycin.

21 January 2018

1 reference

Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression

21 January 2018

1 reference

Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.

21 January 2018

1 reference

In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems

21 January 2018

1 reference

Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.

21 January 2018

1 reference

Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).

21 January 2018

1 reference

68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG.

21 January 2018

1 reference

68Ga-DOTA-Affibody molecule for in vivo assessment of HER2/neu expression with PET

21 January 2018

1 reference

68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression

21 January 2018

1 reference

Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

21 January 2018

1 reference

Indium (III) and gallium (III) complexes of bis(aminoethanethiol) ligands with different denticities: stabilities, molecular modeling, and in vivo behavior

21 January 2018

1 reference

Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration

21 January 2018

1 reference

Synthesis, characterization, and X-ray crystal structure of In(DOTA-AA) (AA = p-aminoanilide): a model for 111In-labeled DOTA-biomolecule conjugates

21 January 2018

1 reference

A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies

21 January 2018

1 reference

Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent

21 January 2018

1 reference

[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study

21 January 2018

1 reference

Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

21 January 2018

1 reference

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

21 January 2018

1 reference

Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy

21 January 2018

1 reference

In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications

21 January 2018

1 reference

Isotachophoretic determination of stability constants of Ho and Y complexes with diethylenetriaminepentaacetic acid and 1,4,7,10-tetraazadodecane-N,N',N'',N'''-tetraacetic acid

21 January 2018

1 reference

213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model

21 January 2018

1 reference

Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial

21 January 2018

1 reference

Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).

21 January 2018

1 reference

Methodology for labeling proteins and peptides with lead-212 (212Pb)

21 January 2018

1 reference

Conjugation of DOTA using isolated phenolic active esters: the labeling and biodistribution of albumin as blood pool marker.

21 January 2018

1 reference

Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins

21 January 2018

1 reference

Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

21 January 2018

1 reference

Search of ligands suitable for (212)Pb/(212)Bi in vivo generators.

21 January 2018

1 reference

212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint

21 January 2018

1 reference

Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51.

21 January 2018

1 reference

Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

21 January 2018

1 reference

Efficient Bifunctional Decadentate Ligand 3p-C-DEPA for Targeted α-Radioimmunotherapy Applications

21 January 2018

1 reference

Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.

21 January 2018

1 reference

[⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.

21 January 2018

1 reference

Copper radionuclides and radiopharmaceuticals in nuclear medicine

21 January 2018

1 reference

Revival of TE2A; a better chelate for Cu(II) ions than TETA?

21 January 2018

1 reference

Non-cross-bridged tetraazamacrocyclic chelator for stable (64)cu-based radiopharmaceuticals

21 January 2018

1 reference

Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms

21 January 2018

1 reference

Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging

21 January 2018

1 reference

Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis

21 January 2018

1 reference

PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference

21 January 2018

1 reference

Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents

21 January 2018

1 reference

Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.

21 January 2018

1 reference

(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity

21 January 2018

1 reference

Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line.

21 January 2018

1 reference

Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling.

21 January 2018

1 reference

In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer

21 January 2018

1 reference

New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr.

21 January 2018

1 reference

Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals

21 January 2018

1 reference

Synthesis of hexa aza cages, SarAr-NCS and AmBaSar and a study of their metal complexation, conjugation to nanomaterials and proteins for application in radioimaging and therapy

21 January 2018

1 reference

Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature

21 January 2018

1 reference

Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides

21 January 2018

1 reference

Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA

21 January 2018

1 reference

Detection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPET

21 January 2018

1 reference

Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics

21 January 2018

1 reference

Efficient synthesis and evaluation of bimodal ligand NETA.

21 January 2018

1 reference

Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.

21 January 2018

1 reference

Synthesis and evaluation of novel polyaminocarboxylate-based antitumor agents

21 January 2018

1 reference

Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies

21 January 2018

1 reference

Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts

21 January 2018

1 reference

NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors

21 January 2018

1 reference

Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.

21 January 2018

1 reference

Radioimmunotherapy of non-Hodgkin's lymphoma: a critical appraisal

21 January 2018

1 reference

PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.

21 January 2018

1 reference

Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma

21 January 2018

1 reference

PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.

21 January 2018

1 reference

Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.

21 January 2018

1 reference

In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.

21 January 2018

1 reference

Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.

21 January 2018

1 reference

Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.

21 January 2018

1 reference

Preparation of the Novel Chelating AgentN-(2-Aminoethyl)-trans-1,2-diaminocyclohexane-N,N‘,N‘‘-pentaacetic Acid (H5CyDTPA), a Preorganized Analogue of Diethylenetriaminepentaacetic Acid (H5DTPA), and the Structures of BiIII(CyDTPA)2-and BiIII(H

21 January 2018

1 reference

Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent

21 January 2018

1 reference

Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation

21 January 2018

1 reference

The influence of Bz-DOTA and CHX-A''-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for (114m)In-mediated targeting therapy.

21 January 2018

1 reference

In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates

21 January 2018

1 reference

Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates

21 January 2018

1 reference

In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation

21 January 2018

1 reference

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

21 January 2018

1 reference

Preclinical characterisation of 111In-DTPA-trastuzumab.

21 January 2018

1 reference

Synthesis and characterization of two (111)In-labeled DTPA-peptide conjugates

21 January 2018

1 reference

Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies

21 January 2018

1 reference

A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates.

21 January 2018

1 reference

Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃.

21 January 2018

1 reference

Reproducibility of quantitative (R)-[11C]verapamil studies

21 January 2018

1 reference

A monoreactive bifunctional triazacyclononane phosphinate chelator with high selectivity for gallium-68.

21 January 2018

1 reference

A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography.

21 January 2018

1 reference

Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects

21 January 2018

1 reference

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience

21 January 2018

1 reference

Equilibrium and kinetic properties of the lanthanoids(III) and various divalent metal complexes of the heptadentate ligand AAZTA.

21 January 2018

1 reference

Selective chelation of Cd(II) and Pb(II) versus Ca(II) and Zn(II) by using octadentate ligands containing pyridinecarboxylate and pyridyl pendants

21 January 2018

1 reference

Eight-coordinate Zn(II), Cd(II), and Pb(II) complexes based on a 1,7-diaza-12-crown-4 platform endowed with a remarkable selectivity over Ca(II).

21 January 2018

1 reference

Zn(ii), Cd(ii) and Pb(ii) complexation with pyridinecarboxylate containing ligands.

21 January 2018

1 reference

Lanthanide complexes based on a 1,7-diaza-12-crown-4 platform containing picolinate pendants: a new structural entry for the design of magnetic resonance imaging contrast agents.

21 January 2018

1 reference

Pyridine- and phosphonate-containing ligands for stable Ln complexation. Extremely fast water exchange on the Gd(III) chelates

21 January 2018

1 reference

The highest water exchange rate ever measured for a Gd(III) chelate

21 January 2018

1 reference

Lanthanide chelates containing pyridine units with potential application as contrast agents in magnetic resonance imaging

21 January 2018

1 reference

RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga

21 January 2018

1 reference

New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake.

21 January 2018

1 reference

"Click-to-chelate": design and incorporation of triazole-containing metal-chelating systems into biomolecules of diagnostic and therapeutic interest

21 January 2018

1 reference

ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature

21 January 2018

1 reference

Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies

21 January 2018

1 reference

Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation.

21 January 2018

1 reference

Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands

21 January 2018

1 reference

89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

21 January 2018

1 reference

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.

21 January 2018

1 reference

Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.

21 January 2018

1 reference

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

21 January 2018

1 reference

Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.

21 January 2018

1 reference

Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab

21 January 2018

1 reference

89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors

21 January 2018

1 reference

H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.

21 January 2018

1 reference

(68)Ga small peptide imaging: comparison of NOTA and PCTA.

21 January 2018

1 reference

(S)-5-(p-nitrobenzyl)-PCTA, a promising bifunctional ligand with advantageous metal ion complexation kinetics

21 January 2018

1 reference

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine

21 January 2018

1 reference

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

21 January 2018

1 reference

Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.

21 January 2018

1 reference

Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system

21 January 2018

1 reference

Standardized methods for the production of high specific-activity zirconium-89.

21 January 2018

1 reference

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

21 January 2018

1 reference

Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.

21 January 2018

1 reference

Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides

21 January 2018

1 reference

Improved in vivo stability of actinium-225 macrocyclic complexes

21 January 2018

1 reference

Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.

21 January 2018

1 reference

Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo

21 January 2018

1 reference

Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga

21 January 2018

1 reference

Synthesis of novel 1,3,5-cis,cis-triaminocyclohexane ligand based Cu(II) complexes as potential radiopharmaceuticals and correlation of structure and serum stability

21 January 2018

1 reference

Novel chelating agents for potential clinical applications of copper

21 January 2018

1 reference

Hexadentate bispidine derivatives as versatile bifunctional chelate agents for copper(II) radioisotopes

21 January 2018

1 reference

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

21 January 2018

1 reference

Mechanism and Energetics for Complexation of90Y with 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA), a Model for Cancer Radioimmunotherapy

21 January 2018

1 reference

A comparative study of aluminum(III), gallium(III), indium(III), and thallium(III) binding to human serum transferrin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1039/C3CS60304K

1 reference

release_5xk76bqclffybodd72m6usvxoy

29 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5xk76bqclffybodd72m6usvxoy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference